Anesthesia Management in Patients with Impaired Renal Function

Preoperative Evaluation and Management

• Patients with impaired renal function (eGFR of 34 mL/min/1.73m²) require specific anesthesia modifications to prevent further renal deterioration and reduce perioperative complications, according to the American Society of Anesthesiologists 1
• Maintain blood pressure at <140/85-90 mmHg preoperatively to prevent renal deterioration 1
• Consider intra-arterial blood pressure monitoring before induction to detect and treat hypotension promptly, as recommended by the American Heart Association 2
• Hold ACE inhibitors/ARBs 24-48 hours before surgery to prevent intraoperative hypotension and acute kidney injury, as suggested by the American College of Cardiology 3
• Discontinue metformin at least 24 hours before surgery due to risk of lactic acidosis, according to the American Diabetes Association 1
• Hold non-insulin oral diabetic medications on the morning of surgery to prevent hypoglycemia, as recommended by the American Diabetes Association 1

Intraoperative Management

• Implement intra-arterial blood pressure monitoring before induction to detect and treat hypotension promptly, as recommended by the American Society of Anesthesiologists 2
• Maintain mean arterial pressure between 60-70 mmHg, or >70 mmHg if the patient is hypertensive, to ensure adequate renal perfusion, according to the American Heart Association 1
• Avoid hypotension defined as >20% drop from baseline systolic blood pressure to prevent renal injury, as suggested by the American Society of Anesthesiologists 2
• Consider advanced hemodynamic monitoring for major or high-risk surgery to guide fluid therapy and vasopressor use, as recommended by the American College of Cardiology 1, 2
• Administer fluids with caution in divided boluses to assess response and avoid volume overload, according to the American Society of Anesthesiologists 2
• Monitor urine output but recognize it may not accurately reflect renal perfusion in CKD, as suggested by the National Kidney Foundation

Anesthetic Agents and Medications

• Adjust anesthetic dosing for patients with renal impairment due to altered pharmacokinetics, as recommended by the American Society of Anesthesiologists 2
• Consider depth of anesthesia monitoring (BIS/entropy) to prevent overdosing, according to the American Society of Anesthesiologists 2
• Use local anesthetics like lidocaine and mepivacaine safely, as suggested by the American Dental Association 4
• Avoid medications with active metabolites that depend on renal clearance, such as opioids, according to the American Pain Society
• Avoid nephrotoxic drugs during the perioperative period, such as aminoglycoside antibiotics and tetracyclines, as recommended by the American Society of Anesthesiologists 1, 4
• Limit contrast media exposure if imaging is required, according to the American College of Radiology

Postoperative Management

• Continue hemodynamic monitoring in the recovery period to detect and treat hypotension promptly, as recommended by the American Society of Anesthesiologists
• Maintain adequate hydration while avoiding volume overload, according to the American Society of Anesthesiologists
• Monitor renal function with serial creatinine measurements, as suggested by the National Kidney Foundation
• Resume ACE inhibitors/ARBs only after confirming stable renal function and hemodynamics, according to the American College of Cardiology 3
• Use acetaminophen, carefully dosed opioids, or regional analgesia techniques for pain management, as recommended by the American Pain Society
• Adjust antibiotic prophylaxis dosing based on renal function, as suggested by the American Society of Anesthesiologists 4
• Monitor electrolyte levels closely, including potassium, calcium, and magnesium, according to the American Society of Anesthesiologists
• Avoid NSAIDs, including meloxicam, in patients with impaired renal function (eGFR <30 mL/min/1.73 m²) due to increased risk of further kidney injury and worsening renal function, as recommended by the European Society of Cardiology and the Mayo Clinic 5, 6
• If NSAIDs are necessary, start with the lowest possible dose (e.g., meloxicam 7.5 mg), monitor renal function within 1-2 weeks, ensure adequate hydration, and discontinue immediately if further decline in renal function is observed, as suggested by the Mayo Clinic 5
• Consider alternative analgesics, such as acetaminophen, tramadol (with dose adjustment), and opioids with no active metabolites (e.g., fentanyl, sufentanil), for patients with impaired renal function, as recommended by the Mayo Clinic 6
• Be aware of the "triple whammy" effect, where the combination of NSAIDs with diuretics and ACE inhibitors/ARBs significantly increases the risk of acute kidney injury, as reported in medical literature 7